Analysis of how much Jisandai (Epclusa) is reimbursed by medical insurance and the actual amount paid by patients

Epclusa (Epclusa/Epclusa), as an oral antiviral drug for the treatment of hepatitis C, has been launched in China and included in the medical insurance catalog. This means that eligible patients can enjoy medical insurance reimbursement when purchasing, thereby reducing the burden of treatment costs. Medical insurance reimbursement ratios and specific policies vary by region and hospital, so patients should consult the hospital pharmacy or medical insurance department before taking medication to obtain accurate reimbursement information.

In the domestic market, the unified retail price of Jisandai is about more than 3,000 yuan per course of treatment. After reimbursement through medical insurance, the actual payment amount of the patient will be significantly reduced. Under normal circumstances, medical insurance can cover a certain percentage of drug costs, and eligible patients may only need to bear part of the out-of-pocket amount. The specific reimbursement amount needs to be calculated based on local medical insurance policies, patient identity and diagnosis and treatment conditions.

In foreign markets, Jisandai also has generic drugs available, such as the Indian and Bangladeshi versions, and the price is only about a few hundred yuan. These generic drugs are basically the same as domestic drugs in terms of drug ingredients and efficacy, providing patients with lower-priced alternatives. For some patients who cannot quickly obtain drugs through domestic channels, they may also consider obtaining them through regular overseas channels, but they must pay attention to the legality and transportation safety of the drugs.

Overall, after Jisandai was included in domestic medical insurance, it has greatly reduced the financial pressure on patients and enabled more hepatitis C patients to afford long-term treatment. When taking medication, patients should take into account medical insurance policies, personal financial conditions and doctor's advice, and rationally arrange drug purchase and treatment courses to ensure that they can obtain drug efficacy while controlling medication costs, and achieve safe and effective antiviral treatment.

Reference materials:https://www.drugs.com/